Blüm Holdings, Inc. | Theralese® Technologies Inc.

Blüm Holdings, Inc. | Theralese® Technologies Inc.

Author: Stock Day Media May 9, 2024 Duration: 0:59
Blüm Holdings, Inc. (OTCQB: BLMH), a cannabis company with operations throughout California, is pleased to announce the execution of a Binding Letter of Intent with Operators Only Corporation to add three additional dispensaries to its retail portfolio. If completed, the Proposed Acquisition could represent a significant milestone in Blüm Holdings’ expansion strategy and may help solidify the Company’s position as a key player in Northern California’s retail landscape.

Operators Only owns and operates three retail stores in Sacramento, including a flagship Cookies cannabis dispensary located in downtown Sacramento, a dispensary in North Sacramento, and another in South Sacramento.

Theralase® Technologies Inc. (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated Photo Dynamic Compounds (“PDCs“) for the safe and effective destruction of various cancers, bacteria and viruses is pleased to announce that Dr. Michael Jewett has joined Theralase®, in the role of an independent consultant, to assist the Company in the completion of enrollment of patients in the Phase II Bacillus Calmette-Guérin (“BCG“)-Unresponsive Non Muscle Invasive Bladder Cancer (“NMIBC“) Carcinoma In-Situ (“CIS“) clinical study.

For more information, please visit StockDayMedia.com
Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy

Tune into Stock Day Media for a direct line to the often-overlooked corners of the market. This podcast cuts through the noise of mainstream financial news to focus squarely on penny and micro-cap stocks, bringing clarity and opportunity to individual investors. Each episode is built on a mission of transparency, offering candid conversations with company executives and deep-dive analyses that you won't find elsewhere. The discussions here are practical and grounded, designed to inform your decisions by shedding light on the potential and the realities of these publicly traded companies. For anyone curious about unique investment avenues, this series connects you with emerging stories and lucrative possibilities before they hit the broader radar. Hosted by the team at Stock Day Media, the content leverages their deep reach within the investment community to source genuine insights. It’s more than just market updates; it’s about understanding the narratives and the numbers that drive smaller-cap ventures. If your interests lie in business news that goes beyond the headlines, this podcast serves as a dedicated resource for building knowledge and discovering what’s next.
Author: Language: English Episodes: 100

Stock Day Media
Podcast Episodes
TC BioPharm CEO, Bryan Kobel, is Featured on The Stock Day Podcast [not-audio_url] [/not-audio_url]

Duration: 18:06
The Stock Day Podcast welcomed TC BioPharm Holdings, PLC. (NASDAQ:TCBP)(“the Company”), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cell therapi…